Change in plasma vascular endothelial growth factor during onset and recovery from acute mountain sickness

Respiratory Medicine

Volumn 101, Issue 3, 2007, Pages 587-594

  Dorward, David A ^a   Roger Thompson, A A ^a   Kenneth Baillie, J ^a   MacDougall, Margaret ^b   Hirani, Nikhil ^c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Acclimatisation; Acute mountain sickness; High altitude; Hypoxia; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN;

ACUTE DISEASE; ADULT; ALTITUDE ACCLIMATIZATION; ALTITUDE DISEASE; ARTICLE; BLOOD SAMPLING; BOLIVIA; CONSENSUS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; OXYGEN SATURATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SCORING SYSTEM; SEA LEVEL RISE; TRAVEL; VENOUS BLOOD;

ACCLIMATIZATION; ACUTE DISEASE; ADOLESCENT; ADULT; ALTITUDE; ALTITUDE SICKNESS; BLOOD PRESSURE; CAPILLARY PERMEABILITY; FEMALE; HUMANS; MALE; OXYGEN; PULMONARY ARTERY; SEX FACTORS; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33846846673     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2006.06.014     Document Type: Article

References (41)

1. Roach R.C., and Hackett P.H. Frontiers of hypoxia research: acute mountain sickness. J Exp Biol 204 (2001) 3161-3170
2. Basnyat B., and Murdoch D.R. High-altitude illness. Lancet 361 (2003) 1967-1974
3. Hackett P.H., and Roach R.C. High altitude cerebral oedema. High Alt Med Biol 5 (2004) 136-146
4. Christou H., Yoshida A., Arthur V., Morita T., and Kourembanas S. Increased vascular endothelial growth factor production in the lungs of rats with hypoxia-induced pulmonary hypertension. Am J Respir Cell Mol Biol 18 (1998) 768-776
5. Claffey K.P., Shih S.C., Mullen A., et al. Identification of a human VPF/VEGF 3' untranslated region mediating hypoxia-induced stability. Mol Biol Cell 9 (1998) 469-481
6. Levy A.P., Levy N.S., Wegner S., and Goldberg M.A. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 270 (1995) 13333-13340
7. 2-regulated gene expression. FASEB J 16 (2002) 1151-1162
8. Fehrenbach H., Kasper M., Haase M., Schuh D., and Muller M. Differential immunolocalisation of VEGF in rat and human lung and in experimental rat lung fibrosis: light fluorescence and electron microscopy. Anat Rec 254 (1999) 61-73
9. Gaudry M., Bregerie O., Andrieu V., Benna J.E., Pocidalo M.A., and Hakim J. Intracellular pool of vascular endothelial growth factor in human neutrophils. Blood 90 (1997) 4153-4161
10. Robinson C.J., and Stringer S.E. The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J Cell Sci 114 (2001) 853-865
11. Neufeld G., Cohen T., Gengrinovitch S., and Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13 (1999) 9-22
12. Schoch H.J., Fischer S., and Marti M.H. Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain. Brain 125 (2002) 2549-2557
13. Severinghaus J.W. Hypothetical roles of angiogenesis, osmotic swelling, and ischemia in high-altitude cerebral edema. J Appl Physiol 79 (1995) 375-379
14. Xu F., and Severinghaus J.W. Rat brain VEGF expression in alveolar hypoxia: possible role in high-altitude cerebral edema. J Appl Physiol 85 (1998) 53-57
15. Maloney J., Wang D., Duncan T., Voelkel N., and Ruoss S. Plasma vascular endothelial growth factor in acute mountain sickness. Chest 118 (2000) 47-52
16. Walter R., Maggiorini M., Scherrer U., Contesse J., and Reinhart W.H. Effects of high-altitude exposure on vascular endothelial growth factor levels in man. Eur J Appl Physiol 85 (2001) 113-117
17. Tissot van Patot M.C., Leadbetter G., Keyes L.E., et al. Greater free plasma VEGF and lower soluble VEGF receptor-1 in Acute Mountain Sickness. J Appl Physiol 98 (2005) 1626-1629
18. Kuo N.T., Benhayon D., Przybylski R.J., Martin R.J., and LaManna J.C. Prolonged hypoxia increases vascular endothelial growth factor mRNA and protein in adult mouse brain. J Appl Physiol 86 (1999) 260-264
19. Patt S., Danner S., Theallier-Janko A., et al. Upregulation of vascular endothelial growth factor in severe chronic brain hypoxia of the rat. Neurosci Lett 252 (1998) 199-202
20. APEX (Altitude Physiological Expeditions) http://www.apex-altitude.com/. Viewed 17th August 2005.
21. Ward MP, Milledge JS, West JB, editors. Acute mountain sickness. High altitude medicine and physiology, 3rd ed. London: Arnold; 2000 [Chapter 18].
22. Allemann Y., Sartori C., Lepori M., et al. Echocardiographic and invasive measurements of pulmonary artery pressure correlate closely at high altitude. Am J Physiol Heart Circ Physiol 279 (2000) H2013-H2016
23. Simes R.J. An improved Bonferroni procedure for multiple tests of significance. Biometrika 73 (1986) 751-754
24. Thickett D.R., Armstrong L., Christie S.J., and Millar A.B. Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome. Am J Respir Crit Care Med 164 (2001) 1601-1605
25. Simler N.R., Brenchley P.E., Horrocks A.W., Greaves S.M., Hasleton P.S., and Egan J.J. Angiogenic cytokines in patients with idiopathic interstitial pneumonia. Thorax 59 (2004) 581-585
26. Pavlicek V., Marti H.H., Grad S., et al. Effects of hypobaric hypoxia on vascular endothelial growth factor and the acute phase response in subjects who are susceptible to high-altitude pulmonary oedema. Eur J Appl Physiol 81 (2000) 497-503
27. Hackett P.H., Roach R.C., Wood R.A., et al. Dexamethasone for prevention and treatment of acute mountain sickness. Aviat Space Environ Med 59 (1988) 950-954
28. Keller H.R., Maggiorini M., Bartsch P., and Oelz O. Simulated descent v dexamethasone in treatment of acute mountain sickness: a randomised trial. Br Med J 310 (1995) 1232-1235
29. Klekamp J.G., Jarzecka K., Hoover R.L., Summar M.L., Redmond N., and Perkett E.A. Vascular endothelial growth factor is expressed in ovine pulmonary vascular smooth muscle cells in vitro and regulated by hypoxia and dexamethasone. Pediatr Res 42 (1997) 744-749
30. Kendall R.L., Wang G., and Thomas K.A. Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem Biophys Res Commun 226 (1996) 324-328
31. Morocz I.A., Zientara G.P., Gudbjartsson H., et al. Volumetric quantification of brain swelling after hypobaric hypoxia exposure. Exp Neurol 168 (2001) 96-104
32. Fischer R., Vollmar C., Thiere M., et al. No evidence of cerebral oedema in severe acute mountain sickness. Cephalalgia 24 (2004) 66-71
33. Swenson E.R., Maggiorini M., Mongovin S., et al. Pathogenesis of high-altitude pulmonary edema: inflammation is not an etiologic factor. J Am Med Assoc 287 (2002) 2228-2235
34. Maggiorini M., Melot C., Pierre S., et al. High-altitude pulmonary edema is initially caused by an increase in capillary pressure. Circulation 103 (2001) 2078-2083
35. Voelkel N.F., Hoeper M., Maloney J., and Tuder R.M. Vascular endothelial growth factor in pulmonary hypertension. Ann NY Acad Sci 796 (1996) 186-193
36. Fischer S., Clauss M., Wiesnet M., Renz D., Schaper W., and Karliczek G.F. Hypoxia induces permeability in brain microvessel endothelial cells via VEGF and NO. Am J Physiol 276 (1999) C812-C820
37. Fischer S., Wobben M., Marti H.H., Renz D., and Schaper W. Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1. Microvasc Res 63 (2002) 70-80
38. Kaner R.J., and Crystal R.G. Compartmentalisation of vascular endothelial growth factor to the epithelial surface of the human lung. Mol Med 7 (2001) 240-246
39. Hanaoka M., Droma Y., Naramoto A., Honda T., Kobayashi T., and Kubo K. Vascular endothelial growth factor in patients with high-altitude pulmonary oedema. J Appl Physiol 94 (2003) 1836-1840
40. Thickett D.R., Armstrong L., and Millar A.B. A role for vascular endothelial growth factor in acute and resolving lung injury. Am J Respir Crit Care Med 166 (2002) 1332-1337
41. Saleem I., Brenchley P.E., Simler N.R., and Egan J.J. VEGF in idiopathic ILD. Thorax 60 (2005) 353-354